In these two newest trials treatment was provided to employing a stable extract of feverfew hugely enriched with parthenolide. On top of that the most recent demo by Diener 2005 used a dosage of 6.25 mg 3 times daily, which had shown probably the most promising ends in the sooner dose‐finding examine by the identical creator team (Pfaffenrath 200